Pharmacy- Page 15

Roche ranked the most sustainable healthcare company in the DJSI

November 16, 2020

Pharmacy

The FINANCIAL — For the eleventh time, Roche has been recognised as the most sustainable company in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI). This is based on an in-depth analysis of economic, social and environmental performance. The DJSI family of indices serves as a benchmark for investors who integrate sustainability considerations into their portfolios. Roche has

Gilead and Novo Nordisk announced new data from proof-of-concept trial in NASH

The FINANCIAL — Gilead Sciences, Inc. and Novo Nordisk A/S announced results

by The FINANCIAL

November 16, 2020

2 mins read

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

The FINANCIAL — Metagenomi, a next generation gene editing company launched by

by The FINANCIAL

November 12, 2020

1 min read

Pharmaceutical industries join to promise fair access to COVID-19 medicines and vaccines

The FINANCIAL — On the occasion of the World Health Assembly, the world’s

by The FINANCIAL

November 12, 2020

1 min read

Pharmacy

Lilly Announces Senior Leadership Appointments for Finance, Research & Development and Manufacturing

The FINANCIAL -- Eli Lilly and Company on September 29 announced a number of leadership changes, promoting several experienced Lilly leaders to executive roles, effective in 2018.

by The FINANCIAL

September 29, 2017

2 mins read

Pharmacy

Roche’s Perjeta regimen gets FDA priority review in breast cancer

The FINANCIAL -- Roche on September 29 announced the US Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) and granted Priority Review for Perjeta (pertuzumab), in combination with Herceptin (trastuzumab) and chemotherapy (the Perjeta-based regimen), for

by The FINANCIAL

September 29, 2017

1 min read

Pharmacy

Bayer cedes control of Covestro

The FINANCIAL -- Bayer has definitively ceded control of Covestro AG. Through the sale of a further 6.9 percent of Covestro shares for EUR 1 billion, the direct interest held by Bayer AG has now been reduced to 24.6 percent.

by The FINANCIAL

September 29, 2017

1 min read

Pharmacy

AbbVie Announces Approval of MAVIRET

The FINANCIAL -- AbbVie on September 27 announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved MAVIRET (glecaprevir/pibrentasvir), a once-daily, ribavirin-free treatment for adults with chronic hepatitis C virus (HCV) infection across all major genotypes (GT1-6).

by The FINANCIAL

September 28, 2017

4 mins read

Pharmacy

Sanofi and Regeneron Announce Approval of Dupixent

The FINANCIAL -- Sanofi and Regeneron Pharmaceuticals, Inc. on September 28 announced that the European Commission has granted marketing authorization for Dupixent (dupilumab), for use in adults with moderate-to-severe atopic dermatitis (AD) who are candidates for systemic therapy.

by The FINANCIAL

September 28, 2017

3 mins read

Pharmacy

Novo Nordisk’s new-generation basal insulin Tresiba approved in China

The FINANCIAL -- Novo Nordisk on September 27 announced that the China Food and Drug Administration (CFDA) has approved Tresiba (insulin degludec) for the treatment of diabetes in China. Tresiba is a new-generation, once-daily basal insulin with an ultra-long duration of action

by The FINANCIAL

September 27, 2017

1 min read

Pharmacy

GSK receives approval for Benlysta in Japan for the treatment of systemic lupus erythematosus

The FINANCIAL -- GSK announced on September 27 that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Benlysta (belimumab) for the treatment of adult patients with systemic lupus erythematosus (SLE) who are inadequate responders to existing therapies.

by The FINANCIAL

September 27, 2017

1 min read

Pharmacy

China Food and Drug Administration Approves Gilead’s Sovaldi

The FINANCIAL -- Gilead Sciences, Inc. announced on September 25 that the China Food and Drug Administration (CFDA) has approved Sovaldi (sofosbuvir 400mg), a once-daily oral nucleotide analog polymerase inhibitor for the treatment of chronic hepatitis C virus (HCV) infection.

by The FINANCIAL

September 25, 2017

3 mins read

Pharmacy

Roche receives European approval for Actemra /RoActemra in giant cell arteritis

The FINANCIAL -- Roche announced on September 22 that the European Commission (EC) has approved Actemra/RoActemra (tocilizumab) for the treatment of giant cell arteritis (GCA), a chronic and potentially life-threatening autoimmune condition.

by The FINANCIAL

September 22, 2017

1 min read

Pharmacy

Roche receives EU approval for Gazyvaro

The FINANCIAL -- Roche announced on September 22 that the European Commission has approved Gazyvaro (obinutuzumab) in combination with chemotherapy, followed by Gazyvaro maintenance in people achieving a response, as a new treatment for previously untreated advanced follicular lymphoma.

by The FINANCIAL

September 22, 2017

1 min read